RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat myeloma: early trial of OPN-6602 begins
Disease control Recruiting nowThis early-phase study tests a new drug called OPN-6602, given alone or with another drug (dexamethasone), in people with multiple myeloma that has returned or stopped responding to at least three prior treatments. The main goal is to check the drug's safety and find the best dos…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Opna Bio LLC • Aim: Disease control
Last updated May 17, 2026 05:24 UTC
-
Can extra antibodies shield myeloma patients from infections during cutting-edge therapy?
Disease control Recruiting nowThis study looks at multiple myeloma patients who are receiving a newer kind of immunotherapy called a BCMA-directed T cell engager. These treatments can weaken the immune system and raise the risk of serious infections. The trial will compare two target levels of immunoglobulin …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE4 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for Hard-to-Treat myeloma: drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a combination of three drugs—talquetamab, iberdomide, and dexamethasone—in 32 adults whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to find the safest dose and check for side effects. Participants must have …
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Alfred Chung, MD • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New 4-Drug cocktail aims to crush myeloma that Won't stay away
Disease control Recruiting nowThis study tests a combination of four drugs (iberdomide, daratumumab, carfilzomib, and dexamethasone) in adults whose multiple myeloma has come back or stopped responding to earlier treatments. The goal is to see if this mix can shrink the cancer to very low levels and keep it f…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Benjamin T Diamond, MD • Aim: Disease control
Last updated May 13, 2026 15:58 UTC